CENTRAL ADELAIDE LOCAL HEALTH NETWORK INC has a total of 11 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are EXPERIMENTAL RES CENTER CHINA ACADEMY OF CHINESE MEDICAL SCIENCES, CANNABICS PHARMACEUTICALS INC and CENTOGENE IP GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | United States | 2 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Measuring microorganism processes | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Lopez Angel | 5 |
#2 | Woodcock Joanna | 3 |
#3 | Pitson Stuart | 2 |
#4 | Gordon Tom | 2 |
#5 | Arentz Georgia | 2 |
#6 | Lopez Angel Francisco | 2 |
#7 | Schwarz Quenten Philip | 2 |
#8 | Hughes Timothy Peter | 1 |
#9 | Coolen Carl | 1 |
#10 | Thompson Emma | 1 |
Publication | Filing date | Title |
---|---|---|
AU2015330955A1 | Modulators of 14-3-3 functionality and uses thereof | |
WO2013185181A1 | Diagnostic method for diseases characterised by ro/la autoimmunity | |
WO2013185180A1 | Method for identifying a diagnostic biomarker for an antibody of interest | |
AU2011235595A1 | A method of modulating protein 14-3-3 functionality by facilitating or inhibiting phosphorylation |